According to immunohistochemical staining, breast cancer can be divided into TNBCs without estrogen and progesterone receptors, HER2 and non-TNBCs with estrogen and progesterone receptors, and HER2 [4,16]. This evidence concerns the gene ERBB2 and breast carcinoma.